Journal
Neuro-Oncology
Publication Date
1-1-2026
Volume
28
Issue
1
First Page
268
Last Page
281
Document Type
Open Access Publication
DOI
10.1093/neuonc/noaf250
Rights and Permissions
Kyle S Smith, Sandeep K Dhanda, Catherine A Billups, Edgar Sioson, Congyu Lu, Airen Zaldivar Peraza, Karishma Gangwani, Yimei Li, Qian Li, Tong Lin, Jeff M Michalski, Roger J Packer, James M Olson, Sarah E S Leary, Maryam Fouladi, Amar Gajjar, Xin Zhou, Arzu Onar-Thomas, Paul A Northcott, Giles W Robinson, An integrated analysis of three medulloblastoma clinical trials refines risk-stratification approaches for reducing toxicity and improving survival, Neuro-Oncology, Volume 28, Issue 1, January 2026, Pages 268–281, https://doi.org/10.1093/neuonc/noaf250. https://academic.oup.com/neuro-oncology/article/28/1/268/8305586?login=true. © The Author(s) 2025. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Recommended Citation
Smith, Kyle S; Michalski, Jeff M; and et al., "An integrated analysis of three medulloblastoma clinical trials refines risk-stratification approaches for reducing toxicity and improving survival." Neuro-Oncology. 28, 1. 268 - 281. (2026).
https://digitalcommons.wustl.edu/oa_4/6441
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
